| Lauryn Velasquez, MS | |
|
9123 Se Saint Helens St Ste 255b, Clackamas, OR 97015-6801 | |
| (503) 974-6774 | |
| Not Available |
| Full Name | Lauryn Velasquez |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 9123 Se Saint Helens St Ste 255b, Clackamas, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134758014 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 016534 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lauryn Velasquez, MS 9123 Se Saint Helens St Ste 255b, Clackamas, OR 97015-6801 Ph: (310) 486-2687 | Lauryn Velasquez, MS 9123 Se Saint Helens St Ste 255b, Clackamas, OR 97015-6801 Ph: (503) 974-6774 |
News Archive
Last year the UK government reclassified cannabis from a class C to a class B drug, partly out of concerns that cannabis, especially the more potent varieties, may increase the risk of schizophrenia in young people. But the evidence for the relationship between cannabis and schizophrenia or psychosis remains controversial.
Hospital superbugs that can break down antibiotics are so widespread throughout Europe that doctors increasingly have to use the few remaining drugs that they reserve for emergencies.
BioSante Pharmaceuticals, Inc. today announced enrollment of the 2,500th woman in the LibiGel (testosterone gel) Phase III cardiovascular and breast cancer safety study. This important enrollment milestone triggers the first unblinded statistical analysis of cardiovascular events by the independent Data Monitoring Committee (DMC), which coincides with their fourth unblinded review of all adverse events.
Data from the GRACE study will be published in the September 21st issue of the Annals of Internal Medicine. GRACE is the largest-ever study of treatment experienced adult women with HIV-1 to examine gender differences in response to HIV therapy. Sponsored by Tibotec Therapeutics Clinical Affairs, a division of Centocor Ortho Biotech Services, LLC, the GRACE study enrolled 67 percent women, demonstrating that it is possible to recruit large numbers of women into U.S.-based HIV treatment studies.
› Verified 2 days ago
Ms. Korynn Underwood, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13455 Se 97th Ave, Clackamas, OR 97015 Phone: 503-675-4000 | |
Mrs. Avital Frumin Rosenfeld, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13455 Se 97th Ave, Clackamas, OR 97015 Phone: 503-662-8148 | |
Ms. Deborah Kallen, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Kaiser Sunnyside Medical Center, 10180 S.e. Sunnyside Road, Clackamas, OR 97015 Phone: 503-571-3820 | |
Haleakala Myers, M.A., SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13455 Se 97th Ave, Clackamas, OR 97015 Phone: 503-675-4000 | |
Jessica Sanchez Jacobson, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10180 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-813-2000 | |
Mr. Chan Y Macdonald, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13455 Se 97th Ave, Clackamas, OR 97015 Phone: 503-908-2979 |